ASMB stock forecast
Our latest prediction for Assembly Biosciences, Inc.'s stock price was made on the July 19, 2018 when the stock price was at 41.18$.
In the short term (2weeks), ASMB's stock price should outperform the market by 1.73%. During that period the price should oscillate between -7.90% and +9.13%.
In the medium term (3months), ASMB's stock price should outperform the market by 0.76%. During that period the price should oscillate between -19.51% and +24.23%.Get email alerts
About Assembly Biosciences, Inc.
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.
At the moment the company generates 15M USD in revenues.
On its last earning announcement, the company reported a loss of -3.77$ per share.
The book value per share is 3.50$
Three months stock forecastJuly 19, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|